BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 22052698)

  • 1. Health problems most commonly diagnosed among young female patients during visits to general practitioners and gynecologists in France before the initiation of the human papillomavirus vaccination program.
    Van Ganse E; Letrilliart L; Borne H; Morand F; Robain M; Siegrist CA
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):261-8. PubMed ID: 22052698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papilloma virus immunization in adolescent and young adults: a cohort study to illustrate what events might be mistaken for adverse reactions.
    Siegrist CA; Lewis EM; Eskola J; Evans SJ; Black SB
    Pediatr Infect Dis J; 2007 Nov; 26(11):979-84. PubMed ID: 17984802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus and papillomavirus vaccines: knowledge, attitudes and intentions of general practitioners and practice nurses in Christchurch.
    Henninger J
    J Prim Health Care; 2009 Dec; 1(4):278-85. PubMed ID: 20690336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HPV vaccination of adult women: an audit of Australian general practitioners.
    Mazza D; Petrovic K; Chakraborty S
    Aust N Z J Obstet Gynaecol; 2012 Dec; 52(6):528-33. PubMed ID: 23046059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing.
    Lutringer-Magnin D; Kalecinski J; Barone G; Leocmach Y; Regnier V; Jacquard AC; Soubeyrand B; Vanhems P; Chauvin F; Lasset C
    Vaccine; 2011 Jul; 29(32):5322-8. PubMed ID: 21616114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?
    Licht AS; Murphy JM; Hyland AJ; Fix BV; Hawk LW; Mahoney MC
    Sex Transm Infect; 2010 Feb; 86(1):74-8. PubMed ID: 19841004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV vaccination catch up program - utilisation by young Australian women.
    Weisberg E; Bateson D; McCaffery K; Skinner SR
    Aust Fam Physician; 2009; 38(1-2):72-6. PubMed ID: 19283241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
    Jaspers L; Budiningsih S; Wolterbeek R; Henderson FC; Peters AA
    Vaccine; 2011 Oct; 29(44):7785-93. PubMed ID: 21821079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV vaccination in France: uptake, costs and issues for the National Health Insurance.
    Fagot JP; Boutrelle A; Ricordeau P; Weill A; Allemand H
    Vaccine; 2011 Apr; 29(19):3610-6. PubMed ID: 21382486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program.
    Brotherton JM; Leask J; Jackson C; McCaffery K; Trevena LJ
    Sex Health; 2010 Sep; 7(3):291-8. PubMed ID: 20719217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescent and young adult HPV vaccination in Australia: achievements and challenges.
    Garland SM; Skinner SR; Brotherton JM
    Prev Med; 2011 Oct; 53 Suppl 1():S29-35. PubMed ID: 21962468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential impact of human papillomavirus vaccines on public STD clinic workloads and on opportunities to diagnose and treat other sexually transmitted diseases.
    Dempsey AF; Koutsky LA; Golden M
    Sex Transm Dis; 2007 Jul; 34(7):503-7. PubMed ID: 17325621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adolescents' awareness of HPV infections and attitudes towards HPV vaccination 3 years following the introduction of the HPV vaccine in Hungary.
    Marek E; Dergez T; Rebek-Nagy G; Kricskovics A; Kovacs K; Bozsa S; Kiss I; Ember I; Gocze P
    Vaccine; 2011 Nov; 29(47):8591-8. PubMed ID: 21939711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reported adverse events in girls aged 13-16 years after vaccination with the human papillomavirus (HPV)-16/18 vaccine in the Netherlands.
    van Klooster TM; Kemmeren JM; van der Maas NA; de Melker HE
    Vaccine; 2011 Jun; 29(28):4601-7. PubMed ID: 21549785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The London low emission zone baseline study.
    Kelly F; Armstrong B; Atkinson R; Anderson HR; Barratt B; Beevers S; Cook D; Green D; Derwent D; Mudway I; Wilkinson P;
    Res Rep Health Eff Inst; 2011 Nov; (163):3-79. PubMed ID: 22315924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceptability of using standing orders to deliver human papillomavirus vaccines in the outpatient obstetrician/gynecologist setting.
    Dempsey AF; Pyrzanowski J; Brewer S; Barnard J; Sevick C; O'Leary ST
    Vaccine; 2015 Apr; 33(15):1773-9. PubMed ID: 25731788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Providing adolescent-friendly HPV education.
    Daley AM
    Nurse Pract; 2011 Nov; 36(11):35-40. PubMed ID: 22008600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females.
    Weiss TW; Zimet GD; Rosenthal SL; Brenneman SK; Klein JD
    J Adolesc Health; 2010 Jul; 47(1):3-11. PubMed ID: 20547286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists.
    Young JL; Bernheim RG; Korte JE; Stoler MH; Guterbock TM; Rice LW
    J Pediatr Adolesc Gynecol; 2011 Dec; 24(6):380-5. PubMed ID: 21906978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.
    Watson M; Shaw D; Molchanoff L; McInnes C
    Aust N Z J Public Health; 2009 Aug; 33(4):365-70. PubMed ID: 19689598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.